Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”

por Xu, Wen-xiong, Peng, Liang
Publicado 2019

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection

por Mei, Yong-yu, Chen, You-ming, Wu, Yuan-kai, Zhang, Xiao-hong, Xu, Wen-xiong
Publicado 2020

Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma

por Ning, Gang, Huang, Yan-Lin, Zhen, Li-Min, Xu, Wen-Xiong, Li, Xue-Jun, Wu, Li-Na, Liu, Ying, Xie, Chan, Peng, Liang
Publicado 2020

Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failur...

por Xu, Wen-xiong, He, Hong-liang, Pan, Shun-wen, Chen, Yuan-li, Zhang, Mei-ling, Zhu, Shu, Gao, Zhi-liang, Peng, Liang, Li, Jian-guo
Publicado 2019

48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse

por Xu, Wen-xiong, Zhang, Qian, Zhu, Xiang, Lin, Chao-shuang, Chen, You-ming, Deng, Hong, Mei, Yong-yu, Zhao, Zhi-xin, Xie, Dong-ying, Gao, Zhi-liang, Xie, Chan, Peng, Liang
Publicado 2018

Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients

por Ning, Gang, Huang, Yan-Lin, Zhen, Li-Min, Xu, Wen-Xiong, Jiao, Qian, Yang, Fang-Ji, Wu, Li-Na, Zheng, Yong-Yuan, Song, Jie, Wang, Yen-Sheng, Xie, Chan, Peng, Liang
Publicado 2018

The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients

por Xu, Wen-Xiong, Li, Yang-Mei, Li, Jian-Guo, Mei, Yong-Yu, Chen, You-Ming, Li, Xue-Jun, Lin, Chao-Shuang, Deng, Hong, Zhao, Zhi-Xin, Xie, Dong-Ying, Gao, Zhi-Liang, Peng, Liang
Publicado 2021